Clustering of patients with intrahepatic cholangiocarcinoma based on serum periostin may be predictive of prognosis

@inproceedings{Thuwajit2017ClusteringOP,
  title={Clustering of patients with intrahepatic cholangiocarcinoma based on serum periostin may be predictive of prognosis},
  author={Chanitra Thuwajit and Peti Thuwajit and Pranisa Jamjantra and Chawalit Pairojkul and Sopit Wongkham and Vajarabhongsa Bhudhisawasdi and Junya Ono and Shoichiro Ohta and Kiminori Fujimoto and Kenji Izuhara},
  booktitle={Oncology letters},
  year={2017}
}
An effective serum biomarker may improve cholangiocarcinoma (CCA) management. Periostin (PN) has been demonstrated to be associated with aggressive CCA. The current study evaluated PN in blood serum for its diagnostic and prognostic potential in patients with CCA. Sera of 68 patients with CCA were collected prior to treatment, and PN levels were measured using an ELISA. Sera from 50 normal controls, 6 patients with benign liver diseases, 2 with hepatocellular carcinoma and 21 with breast cancer… CONTINUE READING